00464nas a2200157   4500000000100000000000100001008004100002100001500043700001600058700001300074700001500087245015500102300001000257490000700267022003200274       2000                            d1 aD. Millson1 aM. Frischer1 aP. Croft1 aP. Goadsby00aAre triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?  a732-70 v20  a0333-1024 (Print) 0333-1024